News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Chelsea Therapeutics, Inc. 2Q Loss Narrows on Gain
August 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Chelsea Therapeutics International Ltd., which is developing a drug candidate to treat low blood pressure, said Wednesday its loss narrowed on a gain from prior impairments on auction-rate securities.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Weight loss
Lilly takes oral obesity race abroad with UK launch of Foundayo
August 25, 2026
·
1 min read
·
Tristan Manalac
Obesity
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
August 24, 2026
·
2 min read
·
Tristan Manalac
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
August 24, 2026
·
1 min read
·
Tristan Manalac
Duchenne muscular dystrophy
Capricor investor calls for change as company awaits decision on Duchenne candidate
August 21, 2026
·
3 min read
·
Heather McKenzie
